Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abound, Alaxia, Amgen, Axon, Betterlife, Biontech, Bristol Myers Squibb, C3.ai, Cebina, Cend, Dr. Reddy’s, Dyadic International, Eisai, Eli Lilly, Emergex, Eyevance, Fosun, Foundation Medicine, Generex, Genexine, Hepion, Hoth, Humanigen, Immunoprecise, Impilo, Janone, Jiangsu Hengrui Medicine, Junshi, Kiadis, Lonza, Mabion, Melior, Mylan, Nanoviricides, Neurorx, Novartis, Novavax, Octimet, Panolos, Pfizer, Pharmajet, Raziel, Relief, Revive, Samsung Biologics, Santen, Shanghai Fosun, Takeda, Teva, Tianjin Juvestar, Tiziana Life Sciences, Tonix, Transcenta Biomedical (Shanghai), Ufovax, Vaxine, Wigen Biomedicine, Xbiotech, Yufan, Zymeworks.